Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Evogene Ltd. (EVGN)

3.09   0.47 (17.94%) 09-20 20:31
Open: 2.7 Pre. Close: 2.62
High: 3.43 Low: 2.67
Volume: 3,617,481 Market Cap: 97M
Evogene Ltd. operates as a plant genomics company. The firm is engaged in developing seed traits for improved yield and abiotic stress tolerance, seed traits for biotic stress resistance, herbicides and bio-stimulants. The firm operates a seed business under its subsidiary Evofuel Ltd. (Evofuel). The company operates through two segments. Its Evogene segment develops seed traits, ag-chemical products, and ag-biological products to improve plant performance. The firm's Evofuel segment develops species of the castor bean plant for second generation feedstock for biofuel and other industrial uses. Its Crop Enhancement (CE) division is developing two types of products: CE seed traits, are seed traits having improved yield and abiotic stress tolerance, and ag-biologicals, which focuses on microbial-based bio-stimulants. The firm's Crop Protection (CP) division is developing two types of products: CP seed traits and ag-chemicals.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.434 - 3.447 3.447 - 3.457
Low: 2.643 - 2.655 2.655 - 2.666
Close: 3.068 - 3.091 3.091 - 3.109

Technical analysis

as of: 2020-09-18 4:30:36 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 4.01     One year: 4.68
Support: Support1: 2.14    Support2: 1.35
Resistance: Resistance1: 3.43    Resistance2: 4.01
Pivot: 2.45
Moving Average: MA(5): 2.71     MA(20): 2.23
MA(100): 1.34     MA(250): 1.38
MACD: MACD(12,26): 0.35     Signal(9): 0.31
Stochastic oscillator: %K(14,3): 73.66     %D(3): 74.89
RSI: RSI(14): 70.48
52-week: High: 3.43  Low: 0.75  Change(%): 88.4
Average Vol(K): 3-Month: 44137  10-Days: 100055

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
EVGN has closed above the upper band by 0.7%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 170% wider than normal. The large width of the bands suggest high volatility as compared to EVGN's normal range. The bands have been in this wide range for 24 bars. This is a sign that the current trend might continue.

Headline News

Fri, 18 Sep 2020
Evogene Ltd. (NASDAQ:EVGN) Stock Jumped 113.82% Year-To-Date, What Analysts Expect Next? - Marketing Sentinel

Fri, 18 Sep 2020
Is Evogene Ltd (EVGN) Stock Worth a Buy Friday? - InvestorsObserver

Wed, 16 Sep 2020
Is Evogene Ltd (EVGN) A Winner in the Healthcare Sector? - InvestorsObserver

Mon, 14 Sep 2020
Where Will Evogene Ltd (EVGN) Stock Go Next After It Is Lower By 7.17% in a Week? - InvestorsObserver

Wed, 09 Sep 2020
Evogene Announces Participation at the HC Wainwright 22nd Annual Global Investment Conference on September 14-16, 2020 (Virtual Conference) - PRNewswire

Thu, 03 Sep 2020
Evogene (EVGN) Raises $10 Million In Equity Led Investment From ARK And Alpha Capital - Pulse 2.0

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 26
Shares Float (M) 21
% Held by Insiders 12.33
% Held by Institutions 28.37
Shares Short (K) 101
Shares Short P. Month (K) 54

Stock Financials

EPS -0.807
EPS Est This Year -0.710
EPS Est Next Year -0.350
Book Value (p.s.) 1.540
Profit Margin
Operating Margin -4074.74
Return on Assets (ttm) -26.0
Return on Equity (ttm) -49.6
Qtrly Rev. Growth 55.2
Gross Profit (p.s.) 0.016
Sales Per Share 0.023
EBITDA (p.s.) -0.847
Qtrly Earnings Growth
Operating Cash Flow (M) -17
Levered Free Cash Flow (M) -10

Stock Valuations

PE Ratio -3.83
PEG Ratio
Price to Book value 2.01
Price to Sales 135.83
Price to Cash Flow -4.81

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.